Effects of nitric oxide donors on basal and K+-evoked release of [3H]noradrenaline from rat cerebral cortex synaptosomes

European Journal of Pharmacology

Volumn 350, Issue 2-3, 1998, Pages 345-351

  Martire, Maria ^a   Altobelli, Debora ^a   Cannizzaro, Carla ^b   Preziosi, Paolo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

1H 1,2,4 oxadiazolo 4,3 quinoxalin 1 one; 3H Noradrenaline release; cGMP; S Nitroso N acetylpenicillamine; Sodium nitroprusside; Synaptosomes, superfused

Indexed keywords

8 BROMO CYCLIC GMP; CALCIUM ION; DESIPRAMINE; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; HEMOGLOBIN; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM CHLORIDE; POTASSIUM ION; QUINOXALINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SYNAPTOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

ANIMALS; CEREBRAL CORTEX; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; HEMOGLOBINS; MALE; NA(+)-K(+)-EXCHANGING ATPASE; NITRIC OXIDE; NITROPRUSSIDE; NOREPINEPHRINE; PENICILLAMINE; POTASSIUM; RATS; RATS, WISTAR; S-NITROSO-N-ACETYLPENICILLAMINE; SYNAPTOSOMES;

EID: 0032486124     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00269-6     Document Type: Article

References (40)

1. Arancio O., Kandel E.R., Hawkins R.D. Activity-dependent long-term enhancement of transmitter release by presynaptic 3′,5′-cyclic GMP in cultured hippocampal neurons. Nature. 376:1995;74-80.
2. Black M.D., Matthews E.K., Humphrey P.P.A. The effects of a photosensitive nitric oxide donor on basal and electrically-stimulated dopamine efflux from the rat striatum in vitro. Neuropharmacology. 33:1994;1357-1365.
3. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
4. Bredt D.S., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
5. Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768-770.
6. Bugnon O., Schaad N.C., Schorderet M. NO modulates endogenous dopamine release in bovine retina. NeuroReport. 5:1994;401-404.
7. Butt E., Geiger J., Jarchau T., Lohmann S.M., Walter U. The cGMP-dependent protein kinase - gene, protein, and function. Neurochem. Res. 18:1993;27-42.
8. 2+ current inhibition in rat sympathetic neurons. J. Physiol. 482.3:1995;521-531.
9. Fallahi N., Broad R.M., Jin S., Fredholm B.B. Release of adenosine from rat hippocampal slices by nitric oxide donors. J. Neurochem. 67:1996;186-193.
10. Fazeli M.S. Synaptic plasticity: on the trail of the retrograde messenger. Trends Neurosci. 15:1992;115-117.
11. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17:1991;S25-S33.
12. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14:1991;60-67.
13. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-α]quinoxalin-1-one. Mol. Pharmacol. 48:1995;184-188.
14. Gray E.G., Whittaker V.P. The isolation of nerve endings from brain: an electron microscope study of cell fragments derived by homogenization and centrifugation. J. Anat. 96:1962;79-87.
15. Guevara-Guzman R., Emson P.C., Kendrick K.M. Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem. 62:1994;807-810.
16. Lauth D., Hertting G., Jackisch R. 3,4-Diaminopyridine-evoked noradrenaline release in rat hippocampal slices: facilitation by endogenous or exogenous nitric oxide. Brain Res. 692:1995;174-182.
17. Lipton S.A., Choi Y.B., Pau Z.-H., Lei S.Z., Cheu H.S., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 344:1993;626-628.
18. 3H] glutamate by striatal synaptosomes J. Neurochem. 63:1994;2108-2117.
19. 3H] norepinephrine release: I. The role of glutamate J. Pharmacol. Exp. Ther. 275:1995;7-13.
20. 3H] norepinephrine release: II. The role of calcium, reverse norepinephrine transport and cyclic 3′,5′-guanosine monophosphate J. Pharmacol. Exp. Ther. 275:1995;14-22.
21. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
22. Martin W., Villani G.M., Jothianandan D., Furchgott R.F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 232:1985;708-716.
23. 2+-independent synaptic vesicle release. Neuron. 12:1994;1235-1244.
24. Meffert M.K., Calakos N.C., Scheller R.H., Schulman H. Nitric oxide modulates synaptic vesicle docking/fusion reactions. Neuron. 16:1996;1229-1236.
25. O'Dell T.J., Hawkins R.D., Kandel E.R., Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrogade messenger. Proc. Natl. Acad. Sci. USA. 88:1991;11285-11289.
26. 3H] GABA release from cerebral cortical neurons is mediated by peroxynitrite J. Neurochem. 65:1995;1109-1114.
27. 2 toxicity. Proc. Natl. Acad. Sci. USA. 89:1992;9715-9719.
28. Prast H., Philippu A. Nitric oxide releases acetylcholine in the basal forebrain. Eur. J. Pharmacol. 216:1992;139-140.
29. Raiteri M., Angelini F., Levi G. A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol. 25:1974;411-414.
30. Satoh S., Kimura T., Toda M., Miyazaki H., Ono S., Narita H., Murayama T., Nomura Y. NO donors stimulate noradrenaline release from rat hippocampus in a calmodulin-dependent manner in the presence of L-cysteine. J. Cell. Physiol. 169:1996;87-96.
31. Schuman E.M., Madison D.V. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science. 254:1991;1503-1506.
32. Seilicovich A., Lasaga M., Befumo M., Duvilanski B.H., Diaz M.D.C., Rettori V., McCann S.M. Nitric oxide inhibits the release of norepinephrine and dopamine from the medial basal hypothalamus of the rat. Proc. Natl. Acad. Sci. USA. 92:1995;11299-11302.
33. Smith J.E., Lane J.D., Shea P.A., McBride W.J., Aprison M.H. A method for concurrent measurement of picomole quantities of acetylcholine, choline, dopamine, norepinephrine, serotonin, 5-hydroxytryptophan, 5-hydroxyindoleacetic acid, tryptophan, tyrosine, glycine, aspartate, glutamate, alanine and gamma-aminobutyric acid in single tissue samples from different areas of rat central nervous system. Anal. Biochem. 64:1975;149-169.
34. 3H] dopamine from rat striatum in vitro J. Neurochem. 66:1996;131-137.
35. 3H] norepinephrine from rat hippocampal slices Neuropharmacology. 33:1994;1367-1374.
36. Vincent S.R., Hope B.T. Neurons that say NO. Trends Neurosci. 15:1992;108-113.
37. Zhu X.-Z., Luo L.-G. Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J. Neurochem. 59:1992;932-935.
38. Zhuo M., Hu Y., Schultz C., Kandel E.R., Hawkins R.D. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature. 368:1994;635-639.
39. Zhuo M., Kandel E.R., Hawkins R.D. Nitric oxide and cGMP can produce either synaptic depression or potentiation depending on the frequency of presynaptic stimulation in the hippocampus. NeuroReport. 5:1994;1033-1036.
40. Zorumski C.F., Izumi Y. Nitric oxide and hippocampal synaptic plasticity. Biochem. Pharmacol. 46:1993;777-785.